Default in plasma and intestinal IgA responses during acute infection by simian immunodeficiency virus

Retrovirology

Yolande Richard⁵  Sophie Prevot³  Roger Le Grand²  Olivier Garraud¹  Martine Raphael⁴  Alexis Proust⁴  Pascale Laurent³  Beatrice Nguyen van Buu³  Sandrine Peruchon¹  Chantal Burelout²  Nada Chaoul² 

[1] EA3064 Université de Lyon, Faculté de Médecine et Etablissement Français du Sang (EFS) Auvergne-Loire, Saint Etienne, F-42023, France;Université Paris-Sud, Orsay, F-91060, France;Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, F-94276, France;INSERM U802, Université Paris-Sud, Le Kremlin-Bicêtre, F-94 724, France;CNRS UMR8104, Paris, France. Institut Cochin. Département d’Immunologie. 27, Rue du Faubourg St Jacques, Paris, F-75014, France

关键词: Terminal ileum;    BAFF;    Germinal centers;    HIV/SIV;    IgA;    Mucosal B-cell response;   

Others  :  1209300
DOI  :  10.1186/1742-4690-9-43

 received in 2012-02-13, accepted in 2012-05-25,  发布年份 2012

【 摘 要 】

Background

Conflicting results regarding changes in mucosal IgA production or in the proportions of IgA plasma cells in the small and large intestines during HIV-infection have been previously reported. Except in individuals repeatedly exposed to HIV-1 but yet remaining uninfected, HIV-specific IgAs are frequently absent in mucosal secretions from HIV-infected patients. However, little is known about the organization and functionality of mucosal B-cell follicles in acute HIV/SIV infection during which a T-dependent IgA response should have been initiated. In the present study, we evaluated changes in B-cell and T-cell subsets as well as the extent of apoptosis and class-specific plasma cells in Peyer’s Patches, isolated lymphoid follicles, and lamina propria. Plasma levels of IgA, BAFF and APRIL were also determined.

Results

Plasma IgA level was reduced by 46% by 28 days post infection (dpi), and no IgA plasma cells were found within germinal centers of Peyer’s Patches and isolated lymphoid follicles. This lack of a T-dependent IgA response occurs although germinal centers remained functional with no sign of follicular damage, while a prolonged survival of follicular CD4+ T-cells and normal generation of IgG plasma cells is observed. Whereas the average plasma BAFF level was increased by 4.5-fold and total plasma cells were 1.7 to 1.9-fold more numerous in the lamina propria, the relative proportion of IgA plasma cells in this effector site was reduced by 19% (duodemun) to 35% (ileum) at 28 dpi.

Conclusion

Our data provide evidence that SIV is unable to initiate a T-dependent IgA response during the acute phase of infection and favors the production of IgG (ileum) or IgM (duodenum) plasma cells at the expense of IgA plasma cells. Therefore, an early and generalized default in IgA production takes place during the acute of phase of HIV/SIV infection, which might impair not only the virus-specific antibody response but also IgA responses to other pathogens and vaccines as well. Understanding the mechanisms that impair IgA production during acute HIV/SIV infection is crucial to improve virus-specific response in mucosa and control microbial translocation.

【 授权许可】

   
2012 Chaoul et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, et al.: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004, 200(6):749-759.
• [2]Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, Rosenzweig M, Johnson RP, Desrosiers RC, Lackner AA: Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998, 280(5362):427-431.
• [3]Suzuki K, Fagarasan S: How host-bacterial interactions lead to IgA synthesis in the gut. Trends Immunol 2008, 29(11):523-531.
• [4]Fagarasan S, Honjo T: Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol 2003, 3(1):63-72.
• [5]Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, Morse HC, Liu C, Schwartzberg PL, Leonard WJ: A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298(5598):1630-1634.
• [6]Cerutti A: The regulation of IgA class switching. Nat Rev Immunol 2008, 8(6):421-434.
• [7]Cazac BB, Roes J: TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 2000, 13(4):443-451.
• [8]Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P: The immune geography of IgA induction and function. Mucosal Immunol 2008, 1(1):11-22.
• [9]Cerutti A, Rescigno M: The biology of intestinal immunoglobulin A responses. Immunity 2008, 28(6):740-750.
• [10]Aloisi F, Pujol-Borrell R: Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006, 6(3):205-217.
• [11]Mackay F, Schneider P, Rennert P, Browning J: BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003, 21:231-264.
• [12]Jain A, Ma CA, Lopez-Granados E, Means G, Brady W, Orange JS, Liu S, Holland S, Derry JM: Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. J Clin Invest 2004, 114(11):1593-1602.
• [13]He B, Xu W, Santini PA, Polydorides AD, Chiu A, Estrella J, Shan M, Chadburn A, Villanacci V, Plebani A, et al.: Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007, 26(6):812-826.
• [14]Peppard J, Kaetzel C, Russell M: Phylogeny and comparative physiolgy of IgA in Mucosal Immunology 3rd Ed. In Mucosal Immunology. Volume 1, edn edition. Edited by Mestecky JOP, McGhee JR, Lambrecht BN, Strober W. Elsevier Science-Academic Press, Amsterdam; 2005:195-210.
• [15]Scinicariello F, Attanasio R: Intraspecies heterogeneity of immunoglobulin alpha-chain constant region genes in rhesus macaques. Immunology 2001, 103(4):441-448.
• [16]Mestecky J, Wright PF, Lopalco L, Staats HF, Kozlowski PA, Moldoveanu Z, Alexander RC, Kulhavy R, Pastori C, Maboko L, et al.: Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women. AIDS Res Hum Retroviruses 2011, 27(5):469-486.
• [17]Devito C, Broliden K, Kaul R, Svensson L, Johansen K, Kiama P, Kimani J, Lopalco L, Piconi S, Bwayo JJ, et al.: Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol 2000, 165(9):5170-5176.
• [18]Tudor D, Derrien M, Diomede L, Drillet AS, Houimel M, Moog C, Reynes JM, Lopalco L, Bomsel M: HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis. Mucosal Immunol 2009, 2(5):412-426.
• [19]Barassi C, Lazzarin A, Lopalco L: CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. Blood 2004, 104(7):2205-2206.
• [20]Nilssen DE, Oktedalen O, Brandtzaeg P: Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy. Gut 2004, 53(4):487-493.
• [21]Bishop PE, McMillan A, Gilmour HM: Immunological study of the rectal mucosa of men with and without human immunodeficiency virus infection. Gut 1987, 28(12):1619-1624.
• [22]Kotler DP, Scholes JV, Tierney AR: Intestinal plasma cell alterations in acquired immunodeficiency syndrome. Dig Dis Sci 1987, 32(2):129-138.
• [23]Raux M, Finkielsztejn L, Salmon-Ceron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, Blondeau C: Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1999, 15(15):1365-1376.
• [24]Schneider T, Zippel T, Schmidt W, Pauli G, Wahnschaffe U, Chakravarti S, Heise W, Riecken EO, Zeitz M, Ullrich R: Increased immunoglobulin G production by short term cultured duodenal biopsy samples from HIV infected patients. Gut 1998, 42(3):357-361.
• [25]Scamurra RW, Nelson DB, Lin XM, Miller DJ, Silverman GJ, Kappel T, Thurn JR, Lorenz E, Kulkarni-Narla A, Janoff EN: Mucosal plasma cell repertoire during HIV-1 infection. J Immunol 2002, 169(7):4008-4016.
• [26]Schafer F, Kewenig S, Stolte N, Stahl-Hennig C, Stallmach A, Kaup FJ, Zeitz M, Schneider T: Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques. Gut 2002, 50(5):608-614.
• [27]McElrath J, Miller CJ: Mucosal Immunity and vaccines against SIV and HIV in Mucosal Immunolgy 3rd Ed. In Mucosal Immunology Volume 1. 3 edn edition. Edited by Mestescky JOP, McGhee JR, Lambrecht BN, Strober W. Elsevier Science-Academic Press, Amsterdam; 2005:937-958.
• [28]Epple HJ, Schneider T, Troeger H, Kunkel D, Allers K, Moos V, Amasheh M, Loddenkemper C, Fromm M, Zeitz M, et al.: Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 2009, 58(2):220-227.
• [29]Brenchley JM, Douek DC: The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008, 3(3):356-361.
• [30]Sankaran S, Guadalupe M, Reay E, George MD, Flamm J, Prindiville T, Dandekar S: Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc Natl Acad Sci U S A 2005, 102(28):9860-9865.
• [31]Xu W, Santini PA, Sullivan JS, He B, Shan M, Ball SC, Dyer WB, Ketas TJ, Chadburn A, Cohen-Gould L, et al.: HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat Immunol 2009, 10(9):1008-1017.
• [32]Peruchon S, Chaoul N, Burelout C, Delache B, Brochard P, Laurent P, Cognasse F, Prevot S, Garraud O, Le Grand R, et al.: Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection. PLoS One 2009, 4(6):e5966.
• [33]Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J: Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003, 19(2):225-234.
• [34]Shaffer AL, Emre NC, Romesser PB, Staudt LM: IRF4: Immunity. Malignancy! Therapy? Clinical cancer research : an official journal of the American Association for Cancer Research 2009, 15(9):2954-2961.
• [35]Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS: Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci U S A 2004, 101(11):3903-3908.
• [36]Hardenberg G, van Bostelen L, Hahne M, Medema JP: Thymus-independent class switch recombination is affected by APRIL. Immunol Cell Biol 2008, 86(6):530-534.
• [37]Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002, 3(9):822-829.
• [38]De Milito A: B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004, 2(1):11-21.
• [39]Hart M, Steel A, Clark SA, Moyle G, Nelson M, Henderson DC, Wilson R, Gotch F, Gazzard B, Kelleher P: Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol 2007, 178(12):8212-8220.
• [40]Titanji K, Chiodi F, Bellocco R, Schepis D, Osorio L, Tassandin C, Tambussi G, Grutzmeier S, Lopalco L, De Milito A: Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS 2005, 19(17):1947-1955.
• [41]Levesque MC, Moody MA, Hwang KK, Marshall DJ, Whitesides JF, Amos JD, Gurley TC, Allgood S, Haynes BB, Vandergrift NA, et al.: Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med 2009, 6(7):e1000107.
• [42]Hamada H, Hiroi T, Nishiyama Y, Takahashi H, Masunaga Y, Hachimura S, Kaminogawa S, Takahashi-Iwanaga H, Iwanaga T, Kiyono H, et al.: Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 2002, 168(1):57-64.
• [43]Tsuji M, Suzuki K, Kitamura H, Maruya M, Kinoshita K, Ivanov II, Itoh K, Littman DR, Fagarasan S: Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 2008, 29(2):261-271.
• [44]Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C: A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 2008, 29(1):127-137.
• [45]Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B: CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 2000, 192(11):1553-1562.
• [46]Vajdy M, Veazey RS, Knight HK, Lackner AA, Neutra MR: Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques. Am J Pathol 2000, 157(2):485-495.
• [47]Zhang ZQ, Casimiro DR, Schleif WA, Chen M, Citron M, Davies ME, Burns J, Liang X, Fu TM, Handt L, et al.: Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infection. Virology 2007, 361(2):455-464.
• [48]Legendre C, Raphael M, Gras G, Lefevre EA, Feuillard J, Dormont D, Richard Y: CD80 expression is decreased in hyperplastic lymph nodes of HIV + patients. Int Immunol 1998, 10(12):1847-1851.
• [49]Frange P, Galimand J, Goujard C, Deveau C, Ghosn J, Rouzioux C, Meyer L, Chaix ML: High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996–2007: the French ANRS CO06 PRIMO Cohort Study. J Antimicrob Chemother 2009, 64(1):135-141.
• [50]Mora JR, Iwata M, Eksteen B, Song SY, Junt T, Senman B, Otipoby KL, Yokota A, Takeuchi H, Ricciardi-Castagnoli P, et al.: Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006, 314(5802):1157-1160.
• [51]Tezuka H, Abe Y, Iwata M, Takeuchi H, Ishikawa H, Matsushita M, Shiohara T, Akira S, Ohteki T: Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 2007, 448(7156):929-933.
• [52]Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, Apetrei C, Poaty-Mavoungou V, Rouquet P, Estaquier J, Mortara L, et al.: Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005, 115(4):1082-1091.
• [53]Ploquin MJ, Desoutter JF, Santos PR, Pandrea I, Diop OM, Hosmalin A, Butor C, Barre-Sinoussi F, Muller-Trutwin MC: Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections. Retrovirology 2006, 3:37. BioMed Central Full Text
• [54]Campillo-Gimenez L, Cumont MC, Fay M, Kared H, Monceaux V, Diop O, Muller-Trutwin M, Hurtrel B, Levy Y, Zaunders J, et al.: AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection. J Immunol 2010, 184(2):984-992.
• [55]Estes JD, Wietgrefe S, Schacker T, Southern P, Beilman G, Reilly C, Milush JM, Lifson JD, Sodora DL, Carlis JV, et al.: Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. J Infect Dis 2007, 195(4):551-561.
• [56]Haase AT: Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005, 5(10):783-792.
• [57]Shacklett BL: Immune responses to HIV and SIV in mucosal tissues: 'location, location, location'. Curr Opin HIV AIDS 2010, 5(2):128-134.
• [58]Schultheiss T, Schulte R, Sauermann U, Ibing W, Stahl-Hennig C: Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues. Retrovirology 2011, 8:24. BioMed Central Full Text